 | Drs. Jaydira Del Rivero & Heloisa Soares with NETRF CEO Elyse Gellerman
in Vienna last month
|
|
ENETS Showcases NETRF Funded Basic & Translational Research
NETRF’s impact on neuroendocrine cancer research was evident at the 20th Annual European Neuroendocrine Tumor Society (ENETS) Conference held March 22-24 in Vienna. The ENETS Conference is a gathering of international NET clinicians and scientists who discuss cutting-edge NET science. About 1,100 researchers, clinicians, and patient advocates attended in person, and more than 300 attended virtually.
Basic and translational research had a higher profile this year. Chrissie Thirlwell, MD, Ph.D, co-chair of NETRF’s Board of Scientific Advisors, delivered a keynote talk with a look at ten years of NET basic research. “It is fantastic to see NETRF grantees more prominent at ENETS,” said Dr. Thirlwell. “The NET research community is collaborating and open to sharing new ideas.”
| |
Deadline: April 24th!
There are just FIVE DAYS LEFT to submit a letter of intent for the NETRF 2023 Research Grant cycle.
We invite transformative basic, translational, and clinical research applications with the potential to advance our understanding of neuroendocrine tumors and their treatment.
NETRF seeks applications from around the world for our Investigator, Pilot, and Mentored Awards. There are specific opportunities for early-career researchers. Awards are one or two years in duration.
NETRF has a two-step application process that begins with the submission of a brief letter of intent.
| |
NANETS/NETRF Research Funding Opportunity
NANETS Basic/Translational Science Investigator supported by NETRF
The North American Neuroendocrine Tumor Society (NANETS) is now accepting applications for its Basic Translational Science Investigator (BTSI) Award, which is funded by NETRF. The purpose of the grant is to encourage scientists at the end of their fellowship, who have secured a faculty appointment, or scientists beginning their faculty appointment, to pursue research focused on neuroendocrine tumors. NETRF has supported the BTSI grant since 2016.
Applications are due by May 31, 2023 by 11:59 pm PST. For eligibility criteria and instructions on how to apply, visit NANETS Grant Portal.
| |
|
Thank You & Save The Date!
We received more than 700 responses to our 2023 Know Your NETs conference content survey! We are so grateful for your efforts and we are looking forward to producing an engaging and informative patient education conference for the NET community this summer.
Please Save The Date! July 22, 2023 NETRF will host our 2023 Know Your NETs Virtual Patient Education Conference. Please watch your email and our social channels for registration information.
| |
NETWise Episode 25: Small Bowel NETs (Updated)
NETRF is committed to always presenting the most current, timely, and credible information about NETs and NET care. Guided by that principle, we have started to refresh older episodes of this series to bring them current. Episode 25 is a revised version of an episode that originally aired in December of 2020, where we focused on diagnosis and treatment of NETs that start in the most common primary site for neuroendocrine tumors, the small intestine.
A special thank you to Dr. Mark Lewis for his expert knowledge and help with this special NETWise update.
| |
New NET Clinical Trial Finder
Looking for a NET clinical trial can feel daunting. There can be many challenges and barriers to searching and finding the right clinical trials for neuroendocrine cancer. A NET clinical trial finder tool is now available and removes the challenges and barriers to this process. Be empowered and learn about the NET clinical trials by visiting NETRF's NET Trial Finder. Thank you to NorCal CarciNet and Josh Mailman for their work with Ancora to make finding NET clinical trials easier for the NET patient community.
| |
Together, We Can Do So MuchThe courage of our NET community across the country and the world inspires us every day. In Illinois, Carrie Camino’s daughters and neighbors hosted a “Cookies for Cancer” fundraiser, a not-your-average bake sale that raised more than $3,000 to benefit NETRF. In Ohio, Brittany White Holzhauer and her family (pictured above) hosted a Winter Gala featuring an energetic night of dueling piano players. Their non-profit organization, The CureNET Project, raised $20,000 in support of NETRF. Through your generosity, we are working to bring life-changing treatments to those living with NETs.
From California to Ohio, in-between and beyond, we invite you to join us at one (or more!) events this year that will benefit NETRF:
July 22, 2023: “A Night to Benefit Sheryl,” a Jimmy Buffet-themed fundraiser in Fair Oaks, California. (Details to come.)
August 26, 2023: CureNET Golf Outing in Elyria, Ohio.
| |
David Metz, MD Joins NETRF Research Committee
NETRF is proud to announce that David Metz, MD is a new community member of the NETRF Research Committee.
Dr. Metz is an internationally recognized leader in the field of NET care and research. Before his retirement in 2021, Dr. Metz was a Professor of Medicine at the Hospital of the University of Pennsylvania and Associate Chief for Clinical Affairs in the Division of Gastroenterology. He is a past President of NANETS, published more than 200 publications on clinical and research topics, and serves on several advisory panels and Boards.
Dr. Metz has been a collaborator on NETRF grants to the University of Pennsylvania to develop CART therapy for NETS. We welcome Dr. Metz and are grateful for his service to NETRF!
| |
| Special thanks to Ipsen for their sponsorship of this E-Newsletter
| |
|
|
|
|
